THE WOODLANDS, Texas — January 7, 2026 — Leads & Copy — Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) will present at the 44th Annual J.P. Morgan Healthcare Conference on Thursday, January 15 at 12:00 p.m. PT (3:00 p.m. ET) in San Francisco, the company announced today.
Management from Lexicon Pharmaceuticals is scheduled to present at the conference.
The live event and replay of the presentations can be accessed on the Events page of the Company’s website at https://investors.lexpharma.com/.
Lexicon Pharmaceuticals is a biopharmaceutical company focused on pioneering medicines. Through its Genome5000™ program, Lexicon’s genomics target discovery platform has studied nearly 5,000 genes and identified over 100 protein targets with therapeutic potential in various diseases. The company has advanced multiple medicines to market and has a pipeline of drug candidates in development for heart failure, neuropathic pain, obesity, cardiology, diabetes and other indications.
Lisa DeFrancesco
Lexicon Pharmaceuticals, Inc.
lexinvest@lexpharma.com
Source: Lexicon Pharmaceuticals
